查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1828143

2025年血脂检查全球市场报告

Lipid Panel Testing Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，血脂检查市场规模强劲成长，从2024年的108.8亿美元增加至2025年的116.1亿美元，复合年增长率为6.7%。预测期内的增长可归因于心血管疾病盛行率的上升、预防保健意识的增强、政府对心血管健康的倡议、生活方式和饮食习惯的改变、人口老龄化以及慢性疾病。

预计未来几年血脂检查市场将强劲成长，到2029年将达到162.7亿美元，复合年增长率为8.8%。预测期内的成长可归因于基因检测和个人化医疗的兴起、对早期检测和预防的重视、家用检测套组的扩展、对基于价值的护理模式的重视以及高危险群筛检的增加。预测期内的主要趋势包括就地检验、与电子健康记录的整合、基因血脂检测、家用检测套组、与远端医疗的整合以及血脂管理的教育倡议。

血脂检查血液测试，用于测量血液中各种脂质（或脂肪）的水平。此测试通常用于评估心血管疾病的风险。

与血脂检查相关的主要产品和服务包括仪器、套件和服务。分析仪等设备用于进行血脂检查。血脂检查的处方模式多种多样，包括处方笺和商店(OTC) 检测。血脂检查适用于多种疾病，包括高血脂症、高三酸甘油脂血症、遗传性高胆固醇症、低脂蛋白血症、丹吉尔氏症和动脉粥状硬化。血脂检查产品和服务的最终使用者包括医院、专科诊所、医生办公室、病理实验室、诊断诊所、门诊手术中心、参考实验室和学术研究机构。

2025年春季美国关税的突然上调及其引发的贸易摩擦对医疗设备行业产生了重大影响，尤其对用于诊断影像设备的进口零件、手术用不銹钢和一次性塑胶製品产生了重大影响。由于医院和诊所抵制涨价，製造商面临利润压力。监管挑战使情况更加复杂，因为由于关税而更换供应商通常需要重新认证医疗设备，导致市场进入延迟。为此，企业正在透过双重采购关键零件、增加标准化产品的国内生产以及加快寻找更具成本效益的材料来降低风险。

本研究报告是商业研究公司 (The Business Research Company) 新报告系列的一部分，该系列提供血脂检查市场统计数据，例如全球市场规模、区域份额、血脂检查血脂检查市场份额的竞争对手、详细的脂质检测细分市场、市场趋势和机会，以及您在血脂检查检测行业血脂检查。本血脂检查市场研究报告对该行业的现状和未来趋势进行了详细分析，为您提供所需的一切观点。

未来五年8.8%的预测成长率，较我们先前对该市场的预测略有下降0.1%。下降主要源自于美国与其他国家之间关税的影响。这可能会直接影响美国，因为美国对来自瑞士和韩国等主要地区的酶促胆固醇试剂和自动化脂蛋白分馏模组征收关税，从而导致心血管风险评估的延迟和预防性筛检成本的增加。由于互惠关税以及贸易紧张局势和限制措施加剧对全球经济和贸易的负面影响，这种影响也将更加广泛地显现。

心血管和糖尿病发病率的预期上升预计将推动血脂检查市场的发展。心血管疾病是一组影响心臟和血管的疾病，而糖尿病是一种影响胰岛素分泌并导致血糖值紊乱，这两者共同导致了血脂检查的需求。这种诊断工具对于识别有心血管疾病风险或心血管疾病的个体至关重要。此外，它还有助于监测治疗效果，使医疗保健提供者能够调整治疗计划以达到目标血脂水平并降低进一步患病的风险。根据世界卫生组织 2023 年 9 月的数据，死于心血管疾病的人数为 1,790 万人。此外，美国疾病管制与预防中心 (CDC) 发布的 2022 年全国糖尿病统计报告指出，美国糖尿病患者数量增加，达 3,730 万人。因此，心血管和糖尿病盛行率的上升预计将推动血脂检查市场的发展。

肥胖率的上升是推动血脂检查市场发展的关键因素。肥胖的特征是体内脂肪堆积过多，会对健康造成不良影响，需要透过血脂检查进行有效评估和管理。这种诊断工具在识别血脂异常症、指导生活方式介入、制定个人化治疗方案、监测治疗效果、早期发现METABOLIC INC.症候群以及评估心血管疾病风险方面发挥关键作用。根据英国政府数位服务局 2023 年 5 月的数据，2021 年至 2022 年间，英格兰 18 岁及以上人口中肥胖率为 25.9%，预计这一数字将增长 25.2%。因此，肥胖率的上升正在推动血脂检查市场的发展。

血脂检查市场的关键趋势是领导企业对产品创新的重视。这些公司致力于开发创新产品以维持其市场地位。例如，2022年10月，美国生技公司波士顿心臟诊断公司（Boston Heart Diagnostics）推出了LipoMap，这是一套包含33项脂质、脂蛋白和载脂蛋白检测的检测方案。 LipoMap提供了市面上最全面的脂质代谢检测评估，并能识别与心血管疾病相关的可治疗和可逆的脂质异常。这项技术创新使治疗和后续检测的个人化成为可能。

血脂检查市场的主要企业正策略性地专注于智慧型手机诊断技术等先进解决方案，以推动市场收益成长。基于智慧型手机的诊断技术利用智慧型手机的功能，提供便利、易用且通常照护现场的解决方案。例如，2022年1月，英国数位健康平台PocDoc推出了一款基于智慧型手机的心血管疾病血脂检查。 PocDoc应用程式可让使用者在家中方便地进行精准、定量的血液胆固醇检测，测量五个对心臟健康至关重要的指标。

2022年10月，美国医疗保健公司CVS Health Corporation与ixlayer Inc.建立伙伴关係。这家美国公司提供脂质检测套组，有助于透过家庭检测扩大医疗保健的可近性。

血脂检查市场的主要企业包括雅培实验室、贝克曼库尔特公司、罗氏公司、朗道实验室有限公司、赛默飞世尔科技公司、PTS Diagnostics、Quest Diagnostics Incorporated、Alere Inc.、EuroMedix International、波士顿心臟诊断公司、Eurofins Scientific SE、Spark Diagnosnostics Pvernos、Evernosu. Biomedical Corporation、Bio-Rad Laboratories Inc.、丹纳赫公司、DiaSorin SpA、EKF Diagnostics Holdings plc、Grifols SA、Hologic Inc.、Luminex Corporation、Meridian Bioscience Inc. 和 Ortho Clinical Diagnostics LLC。

2024年，北美是血脂检查市场最大的地区。预计在预测期内，亚太地区将成为全球血脂检查市场成长最快的地区。血脂检查市场报告涵盖亚太地区、西欧、东欧、北美、南美以及中东和非洲。

血脂检查市场报告涵盖的国家有澳洲、巴西、中国、法国、德国、印度、印尼、日本、俄罗斯、韩国、英国、美国、加拿大、义大利和西班牙

血脂检查市场由提供高胆固醇检测和脂蛋白分析的营业单位所获得的收益所构成。市场价值包括服务供应商销售的或包含在其服务产品中的相关产品的价值。血脂检查市场还包括用于提供检测服务的胆固醇检测套组、血脂谱分析仪和胆固醇自测试剂检测套组的销售额。该市场中的商品价值为“出厂价”，即商品製造商或生产商向其他营业单位（包括下游製造商、批发商、经销商和零售商）或直接向最终客户销售的商品价值。该市场中的商品价值还包括商品製造商销售的任何相关服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球血脂检查：PESTEL分析（政治、社会、技术、环境、法律因素、驱动因素与限制因素）
  • 最终用途产业分析
  • 全球血脂检查市场：成长率分析
  • 全球血脂检查市场表现：规模与成长，2019-2024
  • 全球血脂检查市场预测：规模与成长，2024-2029 年，2034 年
  • 全球血脂检查：总目标市场（TAM）

第六章 市场细分

  • 全球血脂检查市场：依产品/服务、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 装置
  • 套件
  • 服务
  • 全球血脂检查市场（按配方、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • 处方笺测试
  • OTC测试
  • 全球血脂检查市场的应用、性能和预测（2019-2024 年、2024-2029 年、2034 年）
  • 高血脂症
  • 高三酸甘油脂血症
  • 遗传性高胆固醇症
  • 低脂蛋白血症
  • 丹吉尔病
  • 动脉硬化
  • 其他用途
  • 全球血脂检查市场（按最终用户、绩效及预测），2019-2024 年、2024-2029 年、2034 年
  • 医院
  • 专科诊所和医生办公室
  • 病理实验室
  • 诊断诊所
  • 门诊手术中心
  • 参考实验室
  • 学术研究机构
  • 其他最终用户
  • 全球血脂检查市场：按设备类型、性能和预测细分，2019-2024 年、2024-2029 年、2034 年
  • 自动分析仪
  • 就地检验设备
  • 光强度
  • 全球血脂检查市场：按套件类型、性能和预测细分，2019-2024 年、2024-2029 年、2034 年
  • 胆固醇检测套组
  • HDL 和 LDL套件
  • 三酸甘油酯检测套组
  • 全球血脂检查市场：按服务类型、绩效和预测细分，2019-2024 年、2024-2029 年、2034 年
  • 实验室测试服务
  • 诊断服务
  • 健康检查服务

第七章 区域和国家分析

  • 全球血脂检查市场：按地区、绩效和预测，2019-2024 年、2024-2029 年、2034 年
  • 全球血脂检查市场：依国家、绩效及预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 血脂检查市场：竞争格局
  • 血脂检查市场：公司简介
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Beckman Coulter Inc. Overview, Products and Services, Strategy and Financial Analysis
    • F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • Randox Laboratories Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

  • PTS Diagnostics
  • Quest Diagnostics Incorporated
  • Alere Inc.
  • EuroMedix International
  • Boston Heart Diagnostics Corporation
  • Eurofins Scientific SE
  • Spark Diagnostics Pvt Ltd.
  • Everlywell Inc.
  • Horiba ABX SAS
  • Siemens Healthcare GmbH
  • Nova Biomedical Corporation
  • Bio-Rad Laboratories Inc.
  • Danaher Corporation
  • DiaSorin SpA
  • EKF Diagnostics Holdings plc

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章：高潜力市场国家、细分市场与策略

  • 2029 年血脂检查市场：提供新机会的国家
  • 2029 年血脂检查市场：细分市场带来新机会
  • 2029 年血脂检查市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r24270u

Lipid panel testing refers to a blood test that measures the levels of various lipids or fats in the blood. This test is commonly used to assess an individual's risk of developing cardiovascular disease.

The main products and services related to lipid panel testing include devices, kits, and services. Devices, such as analyzer machines, are the equipment used to perform lipid panel testing. The various prescription modes for lipid panel testing include prescription-based testing and over-the-counter (OTC) based testing. Lipid panel testing is applied in various conditions such as hyperlipidemia, hypertriglyceridemia, familial hypercholesterolemia, hypo-lipoproteinamia, Tangier disease, atherosclerosis, and others. The diverse end users of lipid panel testing products and services encompass hospitals, specialty clinics and physician offices, pathology laboratories, diagnostic clinics, ambulatory surgical centers, reference laboratories, academic and research institutes, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The lipid panel testing market research report is one of a series of new reports from The Business Research Company that provides lipid panel testing market statistics, including lipid panel testing industry global market size, regional shares, competitors with a lipid panel testing market share, detailed lipid panel testing market segments, market trends and opportunities, and any further data you may need to thrive in the lipid panel testing industry. This lipid panel testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The lipid panel testing market size has grown strongly in recent years. It will grow from $10.88 billion in 2024 to $11.61 billion in 2025 at a compound annual growth rate (CAGR) of 6.7%. The growth in the historic period can be attributed to increased incidence of cardiovascular diseases, growth in awareness of preventive healthcare, government initiatives for cardiovascular health, lifestyle changes and dietary patterns, aging population and chronic diseases.

The lipid panel testing market size is expected to see strong growth in the next few years. It will grow to $16.27 billion in 2029 at a compound annual growth rate (CAGR) of 8.8%. The growth in the forecast period can be attributed to genetic testing and personalized medicine, focus on early detection and prevention, expansion of home testing kits, focus on value-based care models, increased screening in high-risk populations. Major trends in the forecast period include point-of-care testing, integration with electronic health records, genetic lipid testing, home-based testing kits, telemedicine integration, educational initiatives for lipid management.

The forecast of 8.8% growth over the next five years indicates a slight reduction of 0.1% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through tariffs on enzymatic cholesterol reagents and automated lipoprotein fractionation modules, sourced from key regions such as Switzerland and South Korea, which could lead to slower cardiovascular risk assessments and higher costs for preventive health screenings.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The anticipated increase in cardiovascular and diabetic diseases is poised to drive the growth of the lipid panel testing market. Cardiovascular disease, a cluster of conditions affecting the heart and blood vessels, along with diabetes, a metabolic disorder impacting insulin production and leading to elevated blood sugar levels, collectively contribute to the demand for lipid panel testing. This diagnostic tool is crucial for identifying individuals at risk of developing cardiovascular diseases or those already affected. Additionally, it aids in monitoring treatment effectiveness, enabling healthcare providers to adjust treatment plans to attain target lipid levels and mitigate the risk of further ailments. According to the World Health Organization's data in September 2023, there were 17.9 million deaths attributed to cardiovascular diseases. Furthermore, the Centers for Disease Control and Prevention (CDC) National Diabetes Statistics Report in 2022 indicated an increase in diabetes cases in the US, reaching 37.3 million. Consequently, the escalating prevalence of cardiovascular and diabetic diseases is expected to propel the lipid panel testing market forward.

The rising prevalence of obesity is identified as a significant factor boosting the lipid panel testing market. Obesity, characterized by excessive body fat accumulation with adverse health effects, necessitates effective assessment and management through lipid panel testing. This diagnostic tool plays a crucial role in identifying dyslipidemia, guiding lifestyle interventions, devising personalized treatment plans, monitoring treatment efficacy, detecting metabolic syndrome early, and assessing cardiovascular disease risk. According to the Government Digital Service in May 2023, it was projected that 25.9% of individuals aged 18 and older in England were obese in 2021-2022, reflecting a 25.2% increase. Thus, the growing prevalence of obesity is a driving force behind the lipid panel testing market.

A key trend in the lipid panel testing market is the emphasis on product innovations by major companies. These companies are dedicated to developing innovative products to maintain their market position. For instance, in October 2022, Boston Heart Diagnostics, a US-based biotechnology company, introduced LipoMap-a panel comprising 33 lipid, lipoprotein, and apolipoprotein tests. LipoMap offers one of the most comprehensive assessments of lipid metabolism commercially available, uncovering treatable and reversible lipid abnormalities associated with cardiovascular disease. This innovation allows for greater personalization of treatment and follow-up testing.

Major companies operating in the lipid panel testing market are strategically focusing on advanced solutions, such as smartphone-based diagnostic technologies, to drive market revenues. Smartphone-based diagnostic technologies leverage smartphone capabilities to provide convenient, accessible, and often point-of-care diagnostic solutions. For instance, in January 2022, PocDoc, a UK-based digital health platform, launched a smartphone-based lipid panel test for cardiovascular disease. The PocDoc app enables users to perform a precise, quantitative blood test for cholesterol levels conveniently at home, measuring five essential heart-healthy markers.

In October 2022, CVS Health Corporation, a US-based healthcare company, entered into a partnership with ixlayer Inc. This collaboration aims to enhance global health by making health testing more accessible, affordable, and straightforward through advanced at-home testing kits and digital platforms. ixlayer Inc., a US-based company, provides lipid testing kits, contributing to the expansion of healthcare accessibility through at-home testing.

Major companies operating in the lipid panel testing market include Abbott Laboratories, Beckman Coulter Inc., F. Hoffmann-La Roche Ltd., Randox Laboratories Ltd., Thermo Fisher Scientific Inc., PTS Diagnostics, Quest Diagnostics Incorporated, Alere Inc., EuroMedix International, Boston Heart Diagnostics Corporation, Eurofins Scientific SE, Spark Diagnostics Pvt Ltd., Everlywell Inc., Horiba ABX SAS, Siemens Healthcare GmbH, Nova Biomedical Corporation, Bio-Rad Laboratories Inc., Danaher Corporation, DiaSorin S.p.A., EKF Diagnostics Holdings plc, Grifols S.A., Hologic Inc., Luminex Corporation, Meridian Bioscience Inc., Ortho Clinical Diagnostics LLC

North America was the largest region in the lipid panel testing market in 2024. Asia-Pacific is expected to be the fastest growing region in the global lipid panel testing market during the forecast period. The regions covered in the lipid panel testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the lipid panel testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The lipid panel testing market consists of revenues earned by entities by providing high cholesterol testing and lipoprotein analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. The lipid panel testing market also includes sales of cholesterol test kit, lipid profile analyzer, and cholesterol self-test kit which are used in providing testing services. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Lipid Panel Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on lipid panel testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for lipid panel testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The lipid panel testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product And Services: Devices; Kits; Services
  • 2) By Prescription Mode: Prescription-Based Testing; OTC-Based Testing
  • 3) By Application: Hyperlipidemia; Hypertriglyceridemia; Familial Hypercholesterolemia; Hypo-Lipoproteinemia; Tangier Disease; Atherosclerosis; Other Applications
  • 4) By End User: Hospital; Specialty Clinics And Physician Offices; Pathology Laboratories; Diagnostic Clinics; Ambulatory Surgical Centers; Reference Laboratories; Academic And Research Institutes; Other End-Users
  • Subsegments:
  • 1) By Devices: Automated Analyzers; Point-Of-Care Testing Devices; Spectrophotometers
  • 2) By Kits: Test Kits For Cholesterol; HDL And LDL Kits; Triglyceride Test Kits
  • 3) By Services: Laboratory Testing Services; Diagnostic Services; Health Screening Services
  • Companies Mentioned: Abbott Laboratories; Beckman Coulter Inc.; F. Hoffmann-La Roche Ltd.; Randox Laboratories Ltd.; Thermo Fisher Scientific Inc.; PTS Diagnostics; Quest Diagnostics Incorporated; Alere Inc.; EuroMedix International; Boston Heart Diagnostics Corporation; Eurofins Scientific SE; Spark Diagnostics Pvt Ltd.; Everlywell Inc.; Horiba ABX SAS; Siemens Healthcare GmbH; Nova Biomedical Corporation; Bio-Rad Laboratories Inc.; Danaher Corporation; DiaSorin S.p.A.; EKF Diagnostics Holdings plc; Grifols S.A.; Hologic Inc.; Luminex Corporation; Meridian Bioscience Inc.; Ortho Clinical Diagnostics LLC
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Lipid Panel Testing Market Characteristics

3. Lipid Panel Testing Market Trends And Strategies

4. Lipid Panel Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Lipid Panel Testing Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Lipid Panel Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Lipid Panel Testing Market Growth Rate Analysis
  • 5.4. Global Lipid Panel Testing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Lipid Panel Testing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Lipid Panel Testing Total Addressable Market (TAM)

6. Lipid Panel Testing Market Segmentation

  • 6.1. Global Lipid Panel Testing Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Devices
  • Kits
  • Services
  • 6.2. Global Lipid Panel Testing Market, Segmentation By Prescription Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Prescription-Based Testing
  • OTC-Based Testing
  • 6.3. Global Lipid Panel Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hyperlipidemia
  • Hypertriglyceridemia
  • Familial Hypercholesterolemia
  • Hypo-Lipoproteinamia
  • Tangier Disease
  • Atherosclerosis
  • Other Applications
  • 6.4. Global Lipid Panel Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospital
  • Specialty Clinics And Physician Offices
  • Pathology Laboratories
  • Diagnostic Clinics
  • Ambulatory Surgical Centers
  • Reference Laboratories
  • Academic And Research Institutes
  • Other End-Users
  • 6.5. Global Lipid Panel Testing Market, Sub-Segmentation Of Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Automated Analyzers
  • Point-Of-Care Testing Devices
  • Spectrophotometers
  • 6.6. Global Lipid Panel Testing Market, Sub-Segmentation Of Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Test Kits For Cholesterol
  • HDL And LDL Kits
  • Triglyceride Test Kits
  • 6.7. Global Lipid Panel Testing Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Laboratory Testing Services
  • Diagnostic Services
  • Health Screening Services

7. Lipid Panel Testing Market Regional And Country Analysis

  • 7.1. Global Lipid Panel Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Lipid Panel Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Lipid Panel Testing Market

  • 8.1. Asia-Pacific Lipid Panel Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Lipid Panel Testing Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Lipid Panel Testing Market, Segmentation By Prescription Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Lipid Panel Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Lipid Panel Testing Market

  • 9.1. China Lipid Panel Testing Market Overview
  • 9.2. China Lipid Panel Testing Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Lipid Panel Testing Market, Segmentation By Prescription Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Lipid Panel Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Lipid Panel Testing Market

  • 10.1. India Lipid Panel Testing Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Lipid Panel Testing Market, Segmentation By Prescription Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Lipid Panel Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Lipid Panel Testing Market

  • 11.1. Japan Lipid Panel Testing Market Overview
  • 11.2. Japan Lipid Panel Testing Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Lipid Panel Testing Market, Segmentation By Prescription Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Lipid Panel Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Lipid Panel Testing Market

  • 12.1. Australia Lipid Panel Testing Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Lipid Panel Testing Market, Segmentation By Prescription Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Lipid Panel Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Lipid Panel Testing Market

  • 13.1. Indonesia Lipid Panel Testing Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Lipid Panel Testing Market, Segmentation By Prescription Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Lipid Panel Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Lipid Panel Testing Market

  • 14.1. South Korea Lipid Panel Testing Market Overview
  • 14.2. South Korea Lipid Panel Testing Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Lipid Panel Testing Market, Segmentation By Prescription Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Lipid Panel Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Lipid Panel Testing Market

  • 15.1. Western Europe Lipid Panel Testing Market Overview
  • 15.2. Western Europe Lipid Panel Testing Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Lipid Panel Testing Market, Segmentation By Prescription Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Lipid Panel Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Lipid Panel Testing Market

  • 16.1. UK Lipid Panel Testing Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Lipid Panel Testing Market, Segmentation By Prescription Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Lipid Panel Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Lipid Panel Testing Market

  • 17.1. Germany Lipid Panel Testing Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Lipid Panel Testing Market, Segmentation By Prescription Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Lipid Panel Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Lipid Panel Testing Market

  • 18.1. France Lipid Panel Testing Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Lipid Panel Testing Market, Segmentation By Prescription Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Lipid Panel Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Lipid Panel Testing Market

  • 19.1. Italy Lipid Panel Testing Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Lipid Panel Testing Market, Segmentation By Prescription Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Lipid Panel Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Lipid Panel Testing Market

  • 20.1. Spain Lipid Panel Testing Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Lipid Panel Testing Market, Segmentation By Prescription Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Lipid Panel Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Lipid Panel Testing Market

  • 21.1. Eastern Europe Lipid Panel Testing Market Overview
  • 21.2. Eastern Europe Lipid Panel Testing Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Lipid Panel Testing Market, Segmentation By Prescription Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Lipid Panel Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Lipid Panel Testing Market

  • 22.1. Russia Lipid Panel Testing Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Lipid Panel Testing Market, Segmentation By Prescription Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Lipid Panel Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Lipid Panel Testing Market

  • 23.1. North America Lipid Panel Testing Market Overview
  • 23.2. North America Lipid Panel Testing Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Lipid Panel Testing Market, Segmentation By Prescription Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Lipid Panel Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Lipid Panel Testing Market

  • 24.1. USA Lipid Panel Testing Market Overview
  • 24.2. USA Lipid Panel Testing Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Lipid Panel Testing Market, Segmentation By Prescription Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Lipid Panel Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Lipid Panel Testing Market

  • 25.1. Canada Lipid Panel Testing Market Overview
  • 25.2. Canada Lipid Panel Testing Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Lipid Panel Testing Market, Segmentation By Prescription Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Lipid Panel Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Lipid Panel Testing Market

  • 26.1. South America Lipid Panel Testing Market Overview
  • 26.2. South America Lipid Panel Testing Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Lipid Panel Testing Market, Segmentation By Prescription Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Lipid Panel Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Lipid Panel Testing Market

  • 27.1. Brazil Lipid Panel Testing Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Lipid Panel Testing Market, Segmentation By Prescription Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Lipid Panel Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Lipid Panel Testing Market

  • 28.1. Middle East Lipid Panel Testing Market Overview
  • 28.2. Middle East Lipid Panel Testing Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Lipid Panel Testing Market, Segmentation By Prescription Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Lipid Panel Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Lipid Panel Testing Market

  • 29.1. Africa Lipid Panel Testing Market Overview
  • 29.2. Africa Lipid Panel Testing Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Lipid Panel Testing Market, Segmentation By Prescription Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Lipid Panel Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Lipid Panel Testing Market Competitive Landscape And Company Profiles

  • 30.1. Lipid Panel Testing Market Competitive Landscape
  • 30.2. Lipid Panel Testing Market Company Profiles
    • 30.2.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Beckman Coulter Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Randox Laboratories Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Lipid Panel Testing Market Other Major And Innovative Companies

  • 31.1. PTS Diagnostics
  • 31.2. Quest Diagnostics Incorporated
  • 31.3. Alere Inc.
  • 31.4. EuroMedix International
  • 31.5. Boston Heart Diagnostics Corporation
  • 31.6. Eurofins Scientific SE
  • 31.7. Spark Diagnostics Pvt Ltd.
  • 31.8. Everlywell Inc.
  • 31.9. Horiba ABX SAS
  • 31.10. Siemens Healthcare GmbH
  • 31.11. Nova Biomedical Corporation
  • 31.12. Bio-Rad Laboratories Inc.
  • 31.13. Danaher Corporation
  • 31.14. DiaSorin S.p.A.
  • 31.15. EKF Diagnostics Holdings plc

32. Global Lipid Panel Testing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Lipid Panel Testing Market

34. Recent Developments In The Lipid Panel Testing Market

35. Lipid Panel Testing Market High Potential Countries, Segments and Strategies

  • 35.1 Lipid Panel Testing Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Lipid Panel Testing Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Lipid Panel Testing Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer